{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:30:37Z","timestamp":1779917437462,"version":"3.53.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,8,28]],"date-time":"2017-08-28T00:00:00Z","timestamp":1503878400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Sweish cancer society","award":["CF2014-2016"],"award-info":[{"award-number":["CF2014-2016"]}]},{"name":"Swedish childrens cancer foundation","award":["PR2013-0022"],"award-info":[{"award-number":["PR2013-0022"]}]},{"name":"Marianne and Marcus Wallenbergs Foundation","award":["2013-0117"],"award-info":[{"award-number":["2013-0117"]}]},{"DOI":"10.13039\/501100004348","name":"Stockholm County Council","doi-asserted-by":"crossref","award":["20140451"],"award-info":[{"award-number":["20140451"]}],"id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s12185-017-2320-3","type":"journal-article","created":{"date-parts":[[2017,8,28]],"date-time":"2017-08-28T06:46:47Z","timestamp":1503902807000},"page":"471-475","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Toxicological effects of fludarabine and treosulfan conditioning before allogeneic stem-cell transplantation"],"prefix":"10.1007","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0520-4312","authenticated-orcid":false,"given":"Mats","family":"Remberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"T\u00f6rlen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim El","family":"Serafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Garming-Legert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Bj\u00f6rklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Ljungman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Sundin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moustapha","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,28]]},"reference":[{"issue":"2","key":"2320_CR1","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/sj.bjc.6690043","volume":"79","author":"JA Hartley","year":"1999","unstructured":"Hartley JA, O\u2019Hare CC, Baumgart J. DNA alkylation and interstrand cross-linking by treosulfan. Br J Cancer. 1999;79(2):264\u20136. doi: 10.1038\/sj.bjc.6690043 .","journal-title":"Br J Cancer"},{"issue":"6","key":"2320_CR2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0959-8049(02)00767-0","volume":"39","author":"I Fichtner","year":"2003","unstructured":"Fichtner I, Becker M, Baumgart J. Antileukaemic activity of treosulfan in xenografted human acute lymphoblastic leukaemias (ALL). Eur J Cancer. 2003;39(6):801\u20137.","journal-title":"Eur J Cancer"},{"issue":"5","key":"2320_CR3","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00280-007-0669-3","volume":"62","author":"D Munkelt","year":"2008","unstructured":"Munkelt D, Koehl U, Kloess S, Zimmermann SY, Kalaaoui RE, Wehner S, et al. Cytotoxic effects of treosulfan and busulfan against leukemic cells of pediatric patients. Cancer Chemother Pharmacol. 2008;62(5):821\u201330.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"9","key":"2320_CR4","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/sj.bjc.6600242","volume":"86","author":"J Topaly","year":"2002","unstructured":"Topaly J, Fruehauf S, Ho AD, Zeller WJ. Rationale for combination therapy of chronic myelogenous leukaemia with imatinib and irradiation or alkylating agents: implications for pretransplant conditioning. Br J Cancer. 2002;86(9):1487\u201393.","journal-title":"Br J Cancer"},{"issue":"1","key":"2320_CR5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/pbc.25764","volume":"63","author":"H Boztug","year":"2016","unstructured":"Boztug H, Sykora KW, Slatter M, Zecca M, Veys P, Lankester A, et al. European society for blood and marrow transplantation analysis of treosulfan conditioning before hematopoietic stem cell transplantation in children and adolescents with hematological malignancies. Pediatr Blood Cancer. 2016;63(1):139\u201348.","journal-title":"Pediatr Blood Cancer"},{"issue":"Suppl 2","key":"2320_CR6","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1038\/bmt.2008.287","volume":"42","author":"FK Glowka","year":"2008","unstructured":"Glowka FK, Karazniewicz-Lada M, Grund G, Wrobel T, Wachowiak J. Pharmacokinetics of high-dose i.v. treosulfan in children undergoing treosulfan-based preparative regimen for allogeneic haematopoietic SCT. Bone Marrow Transplant. 2008;42(Suppl 2):S67\u201370.","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"2320_CR7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/bmt.2011.88","volume":"47","author":"I Danylesko","year":"2012","unstructured":"Danylesko I, Shimoni A, Nagler A. Treosulfan-based conditioning before hematopoietic SCT: more than a BU look-alike. Bone Marrow Transplant. 2012;47(1):5\u201314.","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2320_CR8","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/hon.2183","volume":"34","author":"S Claudiani","year":"2016","unstructured":"Claudiani S, Marktel S, Piemontese S, Assanelli A, Lupo-Stanghellini MT, Carrabba M, et al. Treosulfan based reduced toxicity conditioning followed by allogeneic stem cell transplantation in patients with myelofibrosis. Hematol Oncol. 2016;34(3):154\u201360.","journal-title":"Hematol Oncol"},{"issue":"3","key":"2320_CR9","first-page":"233","volume":"35","author":"DW Beelen","year":"2005","unstructured":"Beelen DW, Trenschel R, Casper J, Freund M, Hilger RA, Scheulen ME, et al. Dose-escalated\u00a0treosulphan\u00a0in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complications. BMT. 2005;35(3):233\u201341.","journal-title":"BMT"},{"issue":"12","key":"2320_CR10","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1038\/bmt.2010.343","volume":"46","author":"J Wachowiak","year":"2011","unstructured":"Wachowiak J, Sykora KW, Cornish J, Chybicka A, Kowalczyk JR, Gorczynska E, et al. Treosulfan-based preparative regimens for allo-HSCT in childhood hematological malignancies: a retrospective study on behalf of the EBMT pediatric diseases working party. Bone Marrow Transplant. 2011;46(12):1510\u20138.","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"2320_CR11","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.3324\/haematol.2016.149294","volume":"101","author":"J T\u00f6rlen","year":"2016","unstructured":"T\u00f6rlen J, Ringden O, Garming-Legert K, Ljungman P, Winiarski J, Remes K, et al. A prospective randomized trial comparing cyclosporine\/methotrexate and tacrolimus\/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation. Haematologica. 2016;101(11):1417\u201325.","journal-title":"Haematologica"},{"issue":"2","key":"2320_CR12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3324\/haematol.2016.144139","volume":"102","author":"SR McCurdy","year":"2017","unstructured":"McCurdy SR, Kasamon YL, Kanakry CG, Bola\u00f1os-Meade J, Tsai HL, Showel MM, et al. Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with\u00a0post-transplantation\u00a0cyclophosphamide. Haematologica. 2017;102(2):391\u2013400.","journal-title":"Haematologica"},{"issue":"1","key":"2320_CR13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/01.TP.0000133513.29923.44","volume":"78","author":"M Remberger","year":"2004","unstructured":"Remberger M, Svahn BM, Mattsson J, Ringd\u00e9n O. Dose study of thymoglobulin during conditioning for unrelated donor allogeneic stem-cell transplantation. Transplantation. 2004;78(1):122\u20137.","journal-title":"Transplantation"},{"issue":"8","key":"2320_CR14","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1007\/s00520-014-2190-7","volume":"22","author":"KG Legert","year":"2014","unstructured":"Legert KG, Remberger M, Ringd\u00e9n O, Heimdahl A, Dahll\u00f6f G. Reduced intensity conditioning and oral care measures prevent oral mucositis and reduces days of hospitalization in allogeneic stem cell transplantation recipients. Support Care Cancer. 2014;22(8):2133\u201340.","journal-title":"Support Care Cancer"},{"issue":"4","key":"2320_CR15","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/bmt.2012.239","volume":"48","author":"R Olsson","year":"2013","unstructured":"Olsson R, Remberger M, Schaffer M, Berggren DM, Svahn BM, Mattsson J, Ringd\u00e9n O. Graft failure in the modern era of allogeneic hematopoietic SCT. Bone Marrow Transplant. 2013;48(4):537\u201343.","journal-title":"Bone Marrow Transplant"},{"issue":"24","key":"2320_CR16","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2013-08-519009","volume":"122","author":"C Bredeson","year":"2013","unstructured":"Bredeson C, LeRademacher J, Kato K, Dipersio JF, Agura E, Devine SM, et al. Prospective cohort study comparing intravenous\u00a0busulfan\u00a0to total body irradiation in hematopoietic cell transplantation. Blood. 2013;122(24):3871\u20138.","journal-title":"Blood"},{"issue":"12","key":"2320_CR17","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1182\/blood.V92.12.4568","volume":"92","author":"H H\u00e4gglund","year":"1998","unstructured":"H\u00e4gglund H, Remberger M, Klaesson S, L\u00f6nnqvist B, Ljungman P, Ringd\u00e9n O. Norethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation. Blood. 1998;92(12):4568\u201372.","journal-title":"Blood"},{"issue":"7","key":"2320_CR18","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/sj.bmt.1703229","volume":"28","author":"M Sandstrom","year":"2001","unstructured":"Sandstrom M, Karlsson MO, Ljungman P, Hassan Z, Jonsson EN, Nilsson C, et al. Population pharmacokinetic analysis resulting in a tool for dose individualization of busulphan in bone marrow transplantation recipients. Bone Marrow Transplant. 2001;28(7):657\u201364.","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"2320_CR19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/sj.bmt.1704143","volume":"32","author":"F Sjoo","year":"2003","unstructured":"Sjoo F, Aschan J, Barkholt L, Hassan Z, Ringd\u00e9n O, Hassan M. N-Acetyl-l-cysteine does not affect the pharmacokinetics or myelosuppressive effect of busulfan during conditioning prior to allogeneic stem cell transplantation. Bone Marrow Transplant. 2003;32(4):349\u201354.","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"2320_CR20","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1182\/blood-2001-12-0159","volume":"100","author":"T Ruutu","year":"2002","unstructured":"Ruutu T, Eriksson B, Remes K, Juvonen E, Volin L, Remberger M, et al. Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation. Blood. 2002;100(6):1977\u201383.","journal-title":"Blood"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-017-2320-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-017-2320-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-017-2320-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T20:41:14Z","timestamp":1659386474000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-017-2320-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,28]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["2320"],"URL":"https:\/\/doi.org\/10.1007\/s12185-017-2320-3","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,28]]}}}